Green Line Apothecary Revenue and Competitors

Wakefield, RI USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Green Line Apothecary's estimated annual revenue is currently $7.6M per year.(i)
  • Green Line Apothecary's estimated revenue per employee is $216,000

Employee Data

  • Green Line Apothecary has 35 Employees.(i)
  • Green Line Apothecary grew their employee count by -15% last year.

Green Line Apothecary's People

NameTitleEmail/Phone
1
President & Chief Operating OfficerReveal Email/Phone
2
Director People and CultureReveal Email/Phone
3
Founder, CEO & Director PharmacyReveal Email/Phone
4
Director Operations LogisticsReveal Email/Phone
5
Director Buying and MerchandisingReveal Email/Phone
6
Pharmacy ManagerReveal Email/Phone
7
PharmacistReveal Email/Phone
8
PharmacistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.2M75-3%N/AN/A
#2
$8M379%N/AN/A
#3
$234.6M6951%N/AN/A
#4
$47.8M16173%N/AN/A
#5
$13.1M5410%N/AN/A
#6
$14289.5M378030%N/AN/A
#7
$6.5M307%N/AN/A
#8
$0.8M60%N/AN/A
#9
$21.9M8121%N/AN/A
#10
$51.7M1749%N/AN/A
Add Company

What Is Green Line Apothecary?

What's old is new again. Founded in 2016, Green Line Apothecary is a healthcare company that combines the nostalgic personalized service of vintage drugstores with the efficiency of modern pharmacy. Offering statewide prescription services from two retail locations in Rhode Island, Green Line is redefining the pharmacy experience with a return to the practice's roots. The old-fashioned elegance of its brick-and-mortar stores (complete with vintage soda fountains) goes hand-in-hand with the full-service pharmacy's robust delivery infrastructure. Whether it is a sip of a hand-crafted soda or a medication delivered to your doorstep, Green Line has got just what the doctor ordered.

keywords:N/A

N/A

Total Funding

35

Number of Employees

$7.6M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.6M35-3%N/A
#2
$9.5M363%N/A
#3
$7.3M379%N/A
#4
$7.2M373%N/A
#5
N/A3732%N/A